Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
Phase II Trial of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal Cancer.
Open to Accrual
Anti-Angiogenesis, Chemotherapy: Systemic, Immunomodulator
Defintions of terms and FAQ about clinical trials.
Afsaneh Barzi, M.D.
Other Trial Staff:
Ramona Lujan, R.N., Jiayi Jiang, D.M., Raluca Agafitei, Coordinator, Kristy Sartor Massopust, Coordinator, Noureddine Miloud, D.M.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.